Patent details

EN | LT

LT - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form

EN - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 401/14
		A61K 31/506
		A61P 35/00

European patent
(11)	Number of the document	2535337
(13)	Kind of document	T
(96)	European patent application number	12160493.8
	Date of filing the European patent application	2006-07-18
(97)	Date of publication of the European application	2012-12-19
(45)	Date of publication and mention of the grant of the patent	2017-08-23
(46)	Date of publication of the claims translation

Priority applications
(30)	Number	Date	Country code
	701405 P	2005-07-20	US
	716214 P	2005-09-12	US

Inventors
(72)	Manley, Paul W., CH Shieh, Wen-Chung, US Sutton, Paul Allen, US Karpinski, Piotr H., US Wu, Raeann, US Monnier, Stéphanie, FR Brozio, Jörg, CH

Grantee
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT

Title
(54)	Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form
	Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form